Act of fibulin-1 in preeclamptic patients: can it be a predictive marker?

References

• Liu C, Zhang N, Yu H, et al. Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia. Placenta. 2011;32(2):168–174.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181–192.
   PubMed Web of Science ®Google Scholar
• Practice ACoO. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Am Coll Obstetricians Gynecologists. Int J Gynaecol Obstet: Off Organ Int Federation Gynaecol Obstet. 2002;77(1):67.
   PubMed Web of Science ®Google Scholar
• Roberts J, Lain K. Recent insights into the pathogenesis of pre-eclampsia. Placenta. 2002;23(5):359–372.
   PubMed Web of Science ®Google Scholar
• Huppertz B. The critical role of abnormal trophoblast development in the etiology of preeclampsia. Curr Pharm Biotechnol. 2018;19(10):771–780.
   PubMed Web of Science ®Google Scholar
• Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970–975.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Timpl R, Sasaki T, et al. Fibulin‐1 and fibulin‐2 expression during organogenesis in the developing mouse embryo. Dev Dyn. 1996;205(3):348–364.
   PubMed Web of Science ®Google Scholar
• Mokwatsi GG, Schutte AE, Kruger R. A biomarker of tissue damage, lactate dehydrogenase, is associated with fibulin-1 and oxidative stress in blacks: the SAfrEIC study. Biomarkers. 2016;21(1):48–55.
   PubMed Web of Science ®Google Scholar
• Argraves WS, Tanaka A, Smith EP, et al. Fibulin-1 and fibrinogen in human atherosclerotic lesions. Histochem Cell Biol. 2009;132(5):559–565.
   PubMed Web of Science ®Google Scholar
• Timpl R, Sasaki T, Kostka G, et al. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol. 2003;4(6):479–489.
   PubMed Web of Science ®Google Scholar
• Argraves WS, Tran H, Burgess WH, et al. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol. 1990;111(6 Pt 2):3155–3164.
   PubMed Web of Science ®Google Scholar
• Tran H, Tanaka A, Litvinovich SV, et al. The interaction of fibulin-1 with fibrinogen A potential role in hemostasis and thrombosis. J Biol Chem. 1995;270(33):19458–19464.
   PubMed Web of Science ®Google Scholar
• Godyna S, Diaz-Ricart M, Argraves WS. Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen. Blood. 1996;88:2569–2577.
   PubMed Web of Science ®Google Scholar
• Nakamoto T, Okada H, Nakajima T, et al. Progesterone induces the fibulin-1 expression in human endometrial stromal cells. Hum Reprod. 2005;20(6):1447–1455.
   PubMed Web of Science ®Google Scholar
• Haendler B, Yamanouchi H, Lessey BA, et al. Cycle-dependent endometrial expression and hormonal regulation of the fibulin-1 gene . Mol Reprod Dev. 2004;68(3):279–287.
   PubMed Web of Science ®Google Scholar
• Okada H, Tsuzuki T, Shindoh H, et al. Regulation of decidualization and angiogenesis in the human endometrium: mini review. J Obstet Gynaecol Res. 2014;40(5):1180–1187.
   PubMed Web of Science ®Google Scholar
• Singh U, Sun T, Larsson T, et al. Expression and functional analysis of fibulin-1 (Fbln1) during normal and abnormal placental development of the mouse. Placenta. 2006;27(9–10):1014–1021.
   PubMed Web of Science ®Google Scholar
• Obstetricians ACo, Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122.
   PubMed Web of Science ®Google Scholar
• Wetendorf M, DeMayo FJ. The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network. Mol Cell Endocrinol. 2012;357(1–2):108–118.
   PubMed Web of Science ®Google Scholar
• De Vega S, Iwamoto T, Yamada Y. Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci. 2009;66(11–12):1890–1902.
   PubMed Web of Science ®Google Scholar
• Steegers EAP, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):631–644.
   PubMed Web of Science ®Google Scholar
• Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol. 1996;175(5):1365–1370.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37(3):240–249.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Rabaglino MB, Uiterweer EDP. Emerging role for dysregulated decidualization in the genesis of preeclampsia. Placenta. 2017;60:119–129.
   PubMed Web of Science ®Google Scholar
• Rabaglino MB, Uiterweer ED, Conrad KP, editors. Evidence for partial overlap of molecular etiology between preeclampsia and decidualization disorders. Reprod Sci. 2017;24:91A.
   Web of Science ®Google Scholar
• Kostka G, Giltay R, Bloch W, et al. Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice. Mol Cell Biol. 2001;21(20):7025–7034.
   PubMed Web of Science ®Google Scholar
• Debeer P, Schoenmakers E, Twal W, et al. The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. J Med Genet. 2002;39(2):98–104.
   PubMed Web of Science ®Google Scholar
• Toren A, Rozenfeld‐Granot G, Heath KE, et al. MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation. Am J Hematol. 2003;74(4):254–262.
   PubMed Web of Science ®Google Scholar
• Singh U, Fohn LE, Wakayama T, et al. Different molecular mechanisms underlie placental overgrowth phenotypes caused by interspecies hybridization, cloning, and Esx1 mutation. Dev Dyn. 2004;230(1):149–164.
   PubMed Web of Science ®Google Scholar
• Tran H, Mattei M, Godyna S, et al. Human fibulin-1D: molecular cloning, expression and similarity with S1–5 protein, a new member of the fibulin gene family. Matrix Biol. 1997;15(7):479–493.
   PubMed Web of Science ®Google Scholar
• Redline RW, Chernicky CL, Tan HQ, et al. Differential expression of insulin-like growth factor-II in specific regions of the late (post day 9.5) murine placenta. Mol Reprod Dev. 1993;36(2):121–129.
   PubMed Web of Science ®Google Scholar
• Moll F, Katsaros D, Lazennec G, et al. Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene. 2002;21(7):1097–1107.
   PubMed Web of Science ®Google Scholar
• Qing J, Maher VM, Tran H, et al. Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines. Oncogene. 1997;15(18):2159–2168.
   PubMed Web of Science ®Google Scholar
• Twal WO, Czirok A, Hegedus B, et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci. 2001;114(Pt 24):4587–4598.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.
   PubMed Web of Science ®Google Scholar
• Roark EF, Keene DR, Haudenschild CC, et al. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem. 1995;43(4):401–411.
   PubMed Web of Science ®Google Scholar
• Redfern CH, Degtyarev MY, Kwa AT, et al. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci USA. 2000;97(9):4826–4831.
   PubMed Web of Science ®Google Scholar
• Kawata K, Tanaka A, Arai M, et al. Alteration of plasma fibulin-1 concentrations in ischemic heart diseases. Jpn J Thromb Hemost. 2001;12(2):126–132.
   Google Scholar